INSMED Inc
INSM · XNASCIK 1104506fmd_0H48S8A4TR262AW0709PPC19Y8Manufacturing · Pharmaceutical PreparationsTemplate: Standard
Coverage: Jan 01, 2009 to Sep 30, 2026, 67 periods
| Line item | FY2016 | FY2017 | FY2018 | FY2019 | FY2020 | FY2021 | FY2022 | FY2023 | FY2024 | FY2025 |
|---|---|---|---|---|---|---|---|---|---|---|
| Total revenues | 0 | 0 | 10 | 136 | 164 | 188 | 245 | 305 | 364 | 606 |
| Cost of revenue | 0 | 0 | 2 | 24 | 40 | 44 | 55 | 66 | 86 | 123 |
| Gross profit | 0 | 0 | 7 | 112 | 125 | 144 | 190 | 240 | 278 | 483 |
| Research and development | 123 | 110 | 145 | 132 | 181 | 273 | 398 | 571 | 598 | 771 |
| Selling, general and administrative | – | – | – | – | – | – | 266 | 345 | 461 | 701 |
| Total operating expenses | 173 | 189 | – | – | – | – | – | – | – | – |
| Operating income | (173) | (189) | (307) | (235) | (265) | (375) | (457) | (710) | (878) | (1,247) |
| Interest expense | 3 | 6 | 25 | 28 | 30 | 40 | 26 | 82 | 85 | 84 |
| Other non-operating income (expense) | 0 | 0 | 1 | (1) | 0 | (3) | (6) | 2 | 0 | (2) |
| Income before taxes | (176) | (193) | (324) | (254) | (293) | (436) | (480) | (747) | (910) | (1,272) |
| Income tax expense | 0 | (0) | 0 | 1 | 1 | (2) | 1 | 3 | 4 | 5 |
| Net income from continuing operations | (176) | (193) | (324) | (254) | (294) | (435) | (482) | (750) | (914) | (1,277) |
| Net income | (176) | (193) | (324) | (254) | (294) | (435) | (482) | (750) | (914) | (1,277) |
| Net income to common shareholders | (176) | (193) | (324) | (254) | (294) | (435) | (482) | (750) | (914) | (1,277) |